Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AAD Roundup: Sun Sets Sights On Psoriasis As Competitive Pressures Mount

Feb 22 2018

• By Mandy Jackson

Syringes stuck in a dartboard

Related Content

New Dawn At Novartis As Narasimhan Demands Breakthroughs

Jan 24 2018

LEO Pharma Gets EU Go-Ahead For Psoriasis Latecomer Brodalumab

May 19 2017

Sponsors Flesh Out Profiles of New Dermatology Drugs At AAD Meeting

Mar 06 2017

UCB's Bimekizumab Could Struggle With Saturated Psoriasis Market

Jul 21 2017

US Pricing Squeeze Clouds Sun Pharma Q2; Site Re-Inspection Critical

Nov 15 2017

AstraZeneca Hands LEO Dermatology Potential

Jul 03 2016

Is Triple Phase III Triumph for AbbVie's Risankizumab In Psoriasis Good Enough?

Oct 27 2017

Related Companies

Sun Pharmaceutical Industries Ltd.

Novartis AG

Johnson & Johnson

Johnson & Johnson

Merck & Co., Inc.

Eli Lilly and Company

AbbVie Inc.

Amgen, Inc.

Bristol Myers Squibb Company

UCB S.A.

LEO Pharma A/S

AstraZeneca PLC

Bausch Health Companies Inc.

Additional Topics

Market Access Market Intelligence Research & Development Dermatology BioPharmaceutical

More from Dermatological

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window